Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-26

Clinical Trial Update: Observational Study of Interstitial Glucose Monitoring With Continuous Glucose Monitoring to Track Patients Treated With Exenatide

View source ↗

Summary

A completed observational study evaluating interstitial glucose monitoring using continuous glucose monitoring in patients treated with exenatide for type 2 dia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BYETTA (Exenatide)

Snippet

Sponsor: HealthPartners Institute | Conditions: Diabetes Mellitus Type 2 | Status: COMPLETED